Skip to main content
. 2021 Oct 19;11:109. doi: 10.1186/s13550-021-00845-z

Fig. 1.

Fig. 1

Patients who received both [18F]-F-PSMA-1007 and [68Ga]-Ga-PSMA-11 by indication and device. BCR: Biochemical recurrence; PS: primary staging; FU: follow-up of pre-known metastases